supported by Shenzhen Science and Technology Innovation Commission(JCYJ20220530150412026);Guangdong Basic and Applied Basic Research Foundation(2023A1515111112);Shenzhen Clinical Medical Research Center for Urology and Nephrology。
Hypertension is a known risk factor for clear cell renal cell carcinoma(ccRCC),yet the underlying mechanisms remain elusive.Studies have confirmed that the renin-angiotensin system(RAS)plays a role beyond regulating b...
INTRODUCTION: Since the outcomes associated with the use of renin-angiotensin-system inhibitors (RASi) by hemodialysis (HD) patients are not fully known, we investigated their effect on the cardiovascular mortality of...